Efficacy of HFNC as an Alternative to CPAP Therapy in Surgical Patients With Suspected Moderate to Severe OSA
- Conditions
- OSA
- Interventions
- Device: High flow nasal cannula (HFNC)Device: CPAP face mask
- Registration Number
- NCT05075668
- Lead Sponsor
- Changi General Hospital
- Brief Summary
High flow, humidified, temperature-regulated nasal insufflation is not a new concept. It is used widely in the treatment of hypoxaemic respiratory failure in critically ill patients, as an alternative to non-invasive positive ventilation via face or nasal mask. Recently, its use has been extended to the perioperative setting for pre-oxygenation and prolonging apnoeic time to desaturation. Both CPAP and high flow nasal cannula insufflation devices are licensed for use clinically in Singapore. We conduct this pilot study because its perioperative use in our adult OSA population is currently not well-defined.
- Detailed Description
Continuous positive airway pressure (CPAP) therapy is the only treatment for obstructive sleep apnoea (OSA) shown to reduce its long-term adverse effects on the cardiovascular system. However, due to difficult patient-mask interface and discomfort, compliance rate amongst patients with OSA is low, and reported to be only between 20-50%. High flow, humidified, temperature-regulated nasal cannula insufflation (of air or oxygen) is a well-documented and safe treatment in intensive care, paediatrics and respiratory medicine for patients with hypoxaemic respiratory failure. Its use in adult patients with obstructive sleep apnoea, especially in the perioperative setting is not well studied. Our hospital has a ''fast-track'' protocol for OSA patients who require surgery. They are started on CPAP therapy 2 to 5 days prior to surgery and in the immediate post operative period (ie. perioperatively). If these patients are non-compliant to the CPAP mask device, high flow nasal insufflation is a possible alternative treatment. We aim to randomise these patients into 4 groups, receiving conventional CPAP face mask or high flow nasal cannula at 3 flow rates, and study them with respect to incidence and number of documented desaturations. In addition, patient satisfaction, compliance to device and any adverse events will be monitored.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
- Patients aged 21-85 years old presenting for elective surgery.
- Suspected/possible OSA patients who are enrolled in the "fast-track OSA protocol" in the pre-assessment clinic
- Patients started on CPAP therapy at least one day pre-operatively
- Patients who are admitted to the High Dependency unit for postoperative monitoring.
- Patients with nasal obstruction.
- Patients undergoing nasal or facial surgery, or surgery to treat OSA (eg. uvulopalatopharyngoplasty).
- Patients who already require a higher oxygen concentration (FiO2 > 0.21) preoperatively.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description OSA support via HFNC at 30 L/min High flow nasal cannula (HFNC) High flow nasal insufflation of air (FiO2 0.21) at 30 L/min OSA support via CPAP face mask CPAP face mask Auto-titrated according to the settings made by sleep physicians, FiO2 0.21 OSA support via HFNC at 20 L/min High flow nasal cannula (HFNC) High flow nasal insufflation of air (FiO2 0.21) at 20 L/min OSA support via HFNC at 40 L/min High flow nasal cannula (HFNC) High flow nasal insufflation of air (FiO2 0.21) at 40 L/min
- Primary Outcome Measures
Name Time Method Number of participants with documented desaturations (defined as >4% drop from baseline) 10 hours (between 10pm on first postoperative night and 8am the following day) Number of documented desaturations (defined as \>4% below baseline) in OSA patients who receive CPAP face mask or high flow nasal insufflation on the first postoperative night
- Secondary Outcome Measures
Name Time Method Number of participants with any adverse effects of the applied therapy in the immediate postoperative setting. 10 hours (between 10pm on first postoperative night and 8am the following day) OSA patients who receive CPAP face mask or high flow nasal insufflation on the first
Number of participants who need for supplemental oxygen and/ or the need for other interventions to reverse the desaturations. 10 hours (between 10pm on first postoperative night and 8am the following day) Need for supplemental oxygen and/or the need for other interventions to reverse desaturations in OSA patients who receive CPAP face mask or high flow nasal insufflation on the first postoperative night
Patients' perceptions of the comfort of each device on scale of 0 to 100 10 hours (between 10pm on first postoperative night and 8am the following day) The patients' perceptions of the comfort of CPAP face mask and/ or high flow nasal insufflation
Trial Locations
- Locations (1)
Changi General Hospital
🇸🇬Singapore, Singapore